Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: Role of neuronal activity

Neuropharmacology

Volumn 38, Issue 1, 1999, Pages 121-128

  Mathé, Jan M ^a   Nomikos, George G ^a   Hygge Blakeman, Karin ^a   Svensson, Torgny H ^a  

^a Sect Neuropsychopharmacology   (Sweden)

Author keywords

Dopamine; Medial prefrontal cortex; MK 801; Nucleus accumbens; Tetrodotoxin; Ventral tegmental area

Indexed keywords

DIZOCILPINE; DOPAMINE; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; DIALYSATE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANIMALS; BASAL METABOLISM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIZOCILPINE MALEATE; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICRODIALYSIS; NEURONS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, INBRED STRAINS; TETRODOTOXIN; VENTRAL TEGMENTAL AREA;

EID: 0033046391     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00163-4     Document Type: Article

References (48)

1. Bean A.J., Roth R.H. Extracellular dopamine and neurotensin in rat prefrontal cortex in vivo: effects of median forebrain bundle stimulation frequency, stimulation pattern and dopamine autorecep tors. Journal of Neuroscience. 11:1991;2694-2702.
2. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman-Rakic P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 205:1979;929-932.
3. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1:1988;179-203.
4. Charléty P.J., Grenhoff J., Chergui K., De La Chapelle B., Buda M., Svensson T.H., Chouvet G. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. Acta Physiologica Scandinavica. 142:1991;105-112.
5. Chergui K., Charléty P.J., Akaoka H., Saunier C.F., Brunet J.-L., Buda M., Svensson T.H., Chouvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. European Journal of Neuroscience. 5:1993;137-144.
6. Clineschmidt B.V., Martin G.E., Bunting P.R., Papp N.L. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparently anxiolytic properties. Drug Development Research. 2:1982;135-145.
7. Criswell H.E., Johnson K.B., Mueller R.A., Breese G.R. Evidence for the involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine lesioned rats. Journal Pharmacology Experimental Therapeutics. 265:1993;1001-1010.
8. Enrico P., Bouma M., de Vries J.B., Westerink B.H.C. The role of afferents to the ventral tegmental area in the handling stress-induced increase of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain. Brain Research. 779:1998;205-213.
9. Fessler R.G., Sturgeon R.D., Meltzer H.Y. Effects of phencyclidine and methylphenidate on D-amphetamine-induced behaviors in reserpine pretreated rats. Pharmacology Biochemistry and Behavior. 13:1980;835-842.
10. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
11. Gratton A., Hoffer B.J., Freedman R. Electrophysiological effects of phencyclidine in the medial prefrontal cortex of the rat. Neuropharmacology. 26:1987;1275-1283.
12. Hertel P., Mathé J.M., Nomikos G.G., Iurlo M., Mathé A.A., Svensson T.H. Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behavioral Brain Research. 72:1996;103-114.
13. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry. 148:1991;1301-1308.
14. Jedema H.P., Moghaddam B. Glutamatergic control of dopamine release during stress in the rat prefrontal cortex. Journal of Neurochemistry. 63:1994;785-788.
15. Jentsch J.D., Tran A., Le A., Youngren K.D., Pihl M., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology. 17:1997;92-99.
16. Kalivas P.W., Duffy P., Barrow J. Regulation of the mesocorticolimbic dopamine system by glutamic acid subtypes. Journal of Pharmacology and Experimental Therapeutics. 251:1989;378-387.
17. Kashiwa A., Nishikawa T., Nishijima K., Umino A., Takahashi K. Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial prefrontal cortex. Neurochemistry International. 26:1995;269-279.
18. Kornhuber J.M., Weller M. Predicting psychotomimetic properties of PCP-like NMDA receptor antagonists. Fog R., Gerlach J., Hemmingsen R. Schizophrenia, Alfred Benzon Symposium. 38:1995;314-325 Munksgaard, Copenhagen.
19. Mathé J.M., Nomikos G.G., Hildebrand B.E., Hertel P., Svensson T.H. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. European Journal of Pharmacology. 309:1996;1-11.
20. Mathé J.M., Schilström B., Nomikos G.G., Svensson T.H. Non-NMDA receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. Journal of Neuroscience Research. 51:1998;583-592.
21. Mirenowicz J., Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature. 379:1996;449-451.
22. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Journal of Neuroscience. 17:1997;2921-2927.
23. Morrow B.A., Clark W.A., Roth R.H. Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist. European Journal of Pharmacology. 238:1993;255-262.
24. Murase S., Mathé J.M., Grenhoff J., Svensson T.H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions related to anatomical localization. Journal of Neural Transmission [Gen. Sect.]. 91:1993;13-25.
25. Murphy B.L., Arnsten A.F.T, Jentsch J.D., Roth R.H. Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. Journal of Neuroscience. 16:1996;7768-7775.
26. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. Acute effects of buproprion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology. 2:1989;273-279.
27. Nomikos G.G., Iurlo M., Andersson J.L., Kimura K., Svensson T.H. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology. 115:1994;147-156.
28. Pawlowski L., Mathé J.M., Svensson T.H. Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization. Acta Physiologica Scandinavica. 139:1990;529-530.
29. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 4th edition:1998;Academic Press, London.
30. Sawaguchi T., Goldman-Rakic P.S. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkey performing an oculomotor delayed-response task. Journal of Neurophysiology. 71:1994;515-528.
31. Schilström B., Nomikos G.G., Nisell M., Hertel P., Svensson T.H. NMDA receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience. 82:1998;781-789.
32. Schultz W., Apicella P., Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. Journal of Neuroscience. 13:1993;900-913.
33. Schultz W. The phasic reward signal of primate dopamine neurons. Goldstein D.S., Eisenhofer G., McCarty R. Catecholamines: Bridging Basic Science with Clinical Medicine, Advances in Pharmacology. 1998;686-690 Academic Press, San Diego.
34. Svensson T.H., Tung C.-S. Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiologica Scandinavica. 136:1989;135-136.
35. Svensson T.H., Mathé J.M., Andersson J.L., Nomikos G.G., Hildebrand B.E., Marcus M. Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 and α1-adrenoreceptor antagonism. Journal of Clinical Psychopharmacology. 15:1995;11S-18.
36. Svensson T.H., Mathé J.M., Nomikos G.G., Schilström B., Marcus M., Fagerquist M. Interactions between catecholamines and serotonin: relevance to the pharmacology of schizophrenia. Goldstein D.S., Eisenhofer G., McCarty R. Catecholamines: Bridging Basic Science with Clinical Medicine, Advances in Pharmacology. 1998;814-818 Academic Press, San Diego.
37. Taber M.T., Das S., Fibiger H.C. Cortical regulation of subcortical dopamine release: mediation by the ventral tegmental area. Journal of Neurochemistry. 65:1995;1407-1410.
38. Thierry A.M., Pirot S., Gioanni Y., Glowinski J. Dopamine function in the prefrontal cortex. Goldstein D.S., Eisenhofer G., McCarty R. Catecholamines: Bridging Basic Science with Clinical Medicine, Advances in Pharmacology. 1998;717-720 Academic Press, San Diego.
39. Tong Z.-Y., Overton P.G., Clark D. Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex. Journal of Neural Transmission. 103:1996;889-905.
40. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. Journal of Neuroscience. 16:1996;373-379.
41. Wedzony K., Klimek V., Golembiowska K. MK-801 elevates the etracellular concentration of dopamine in the rat medial prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Research. 622:1993;325-329.
42. Weinberger D.R, Aiola M.S., Goldberg T.E., Berman K.F. The frontal lobes and schizophrenia. Journal Neuropsychiatry and Clinical Neuroscience. 6:1994;419-427.
43. Westerink B.H., Tuntler J., Damsma G., Rollema H., de Vries J.B. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis, Naunyn-Schmiedeberg's. Archives of Pharmacology. 336:1987;502-507.
44. Westerink B.H.C., Kwint H.-F., de Vries J.B. Eating-induced dopamine release from mesolimbic neurons is mediated by NMDA receptors in the ventral tegmental area: a dual-probe microdialysis study. Journal of Neurochemistry. 69:1997;662-668.
45. Westerink B.H.C., Enrico P., Feinman J., de Vries J.B. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat. Journal of Pharmacology and Experimental Therapeutics. 285:1998;143-154.
46. Williams G.H., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1997;572-575.
47. Wolf M.E., White F.J., Hu X.T. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behavioral Pharmacology. 4:1993;429-442.
48. Yonezawa Y., Kuroki T., Kawahara T., Tashiro N., Uchimura H. Involvement of α-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. European Journal of Pharmacology. 341:1998;45-56.